Team:ULB-Brussels/sponsors
From 2011.igem.org
(Difference between revisions)
Line 572: | Line 572: | ||
<table> | <table> | ||
<tr> | <tr> | ||
- | <td><a href="http://www.ucb.com/"> | + | <td><a href="http://www.ucb.com/"><img src="https://static.igem.org/mediawiki/2011/a/a4/Logo-ucb.png" alt="UCB's logo" /></a> |
- | <img src="https://static.igem.org/mediawiki/2011/a/a4/Logo-ucb.png" alt="UCB's logo" /> | + | |
<td><em>UCB</em>, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels.</td> | <td><em>UCB</em>, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels.</td> | ||
</tr> | </tr> |
Revision as of 09:18, 21 September 2011
Sponsors
iGEM ULB Brussels Team - Contact us